Another ACVR1 purification for fragment screening and co-crystallisation
Main Authors: | Adamson, Roslin, Matteucci, Mizio, Brennan, Paul, Bullock, Alex |
---|---|
Format: | Article |
Terbitan: |
, 2018
|
Subjects: | |
Online Access: |
https://zenodo.org/record/1230514 |
Daftar Isi:
- A rather unsuccessful purification, but nevertheless, enough for three crystal plates to follow up compound conditions
- The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z].